BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics
01 September 2020
The BEAM Alliance and the co-signatories of this paper urge the EU and its Member States to urgently act and fix the broken economics around investment into the development and commercialization of antimicrobials.
Further reading: BEAM Alliance
Author(s): BEAM Alliance
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!